Thereover, In the in vivo and in vitro models, we proved that overexpression of TRIM 33 significantly inhibited the expression of TGF-β1 induced by Ang II in CFs, thereby disrupting the Smad signaling pathway and reducing CF fibrosis. This evidence concerns the gene TGFB1 and myalgic encephalomeyelitis/chronic fatigue syndrome.